Metabolic engineering as an integrating platform for strain development

Current Opinion in Microbiology

Volumn 4, Issue 3, 2001, Pages 336-340

  Stafford, Daniel E ^a   Stephanopoulos, Gregory ^a  

^a Massachusetts Institute of Technology Cambridge   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL GENE; BACTERIAL METABOLISM; BIOTECHNOLOGY; DIRECTED MOLECULAR EVOLUTION; DNA MICROARRAY; GENETIC VARIABILITY; NONHUMAN; REVIEW; STRAIN DIFFERENCE;

EID: 0034992791     PISSN: 13695274     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1369-5274(00)00214-9     Document Type: Review

References (49)

1. Toward a science of metabolic engineering
2. Metabolic fluxes and metabolic engineering
3. Homofermentative production of D- or L-lactate in metabolically engineered Escherichia coli RR1
4. Metabolic engineering of indene bioconversion in Rhodococcus sp.
5. Harnessing the biosynthetic code: Combinations, permutations, and mutations
6. Metabolic flux distributions in Corynebacterium glutamicum during growth and lysine overproduction
7. Metabolic engineering of a 1,2-propanediol pathway in Escherichia coli
8. Increasing galactose consumption by Saccharomyces cerevisiae through metabolic engineering of the GAL gene regulatory network
9. Improving lycopene production in Escherichia coli by engineering metabolic control
10. Quantification of metabolites in the indole alkaloid pathways of Catharanthus roseus: Implications for metabolic engineering
11. Regulated multicistronic expression technology for mammalian metabolic engineering
12. The impact of mammalian gene regulation concepts on functional genomic research, metabolic engineering, and advanced gene therapies
13. Metabolic flux analysis of hybridoma continuous culture steady state multiplicity
14. Gene expression tools for the metabolic engineering of bacteria
15. Analysis of the pathway structure of metabolic networks
16. Network rigidity and metabolic engineering in metabolite overproduction
17. A metabolic control analysis of kinetic controls in ATP free energy metabolism in contracting skeletal muscle
18. Metabolic control analysis: A survey of its theoretical and experimental development
19. Intracellular flux analysis in hybridomas using mass balances and in vitro C-13 NMR
20. Determination of flux control coefficients from transient metabolite concentrations
21. Metabolite and isotopomer balancing in the analysis of metabolic cycles: I. Theory
22. Modeling isotopomer distributions in biochemical networks using isotopomer mapping matrices
23. In vivo quantification of parallel and bidirectional fluxes in the anaplerosis of Corynebacterium glutamicum
24. Detecting and dissecting metabolic fluxes using biosynthetic fractional 13C labeling and two-dimensional NMR spectroscopy
25. Mass spectrometry for metabolic flux analysis
26. Bidirectional reaction steps in metabolic networks 2. Flux estimation and statistical analysis
27. 13C]glucose: Molecular condensation requires a molecular approach
28. Metabolic network analysis of Penicillium chrysogenum using C-13-labeled glucose
29. Lessons from metabolic engineering for functional genomics and drug discovery
30. Exploring the new world of the genome with DNA microarrays
31. An antisense-based functional genomics approach for identification of genes critical for growth of Candida albicans
32. Large-scale identification of secreted and membrane-associated gene products using DNA microarrays
33. Genome-wide location and function of DNA binding proteins
34. Directed evolution: The 'rational' basis for 'irrational design'
35. Directed evolution of metabolically engineered Escherichia coli for carotenoid production
36. Laboratory evolution of peroxide-mediated cytochrome P450 hydroxylation
37. Directed evolution of a (beta alpha)8-barrel enzyme to catalyze related reactions in two different metabolic pathways
38. Molecular breeding of carotenoid biosynthetic pathways
39. Enhanced production of (R)-1,2-propanediol by metabolically engineering Escherichia coli
40. Proteome analysis of metabolically engineered Escherichia coli producing poly(3-hydroxybutyrate)
41. Natural product biosynthesis: A new interface between enzymology and medicine
42. Heterologous expression, purification, reconstitution and kinetic analysis of an extended type II polyketide synthase
43. Advances in AIDS chemotherapy: The asymmetric synthesis of CRIXlVAN
44. Clinically effective HIV-1 protease inhibitors
45. Advantages and disadvantages of aggregating fluxes into synthetic and degradative fluxes when modelling metabolic pathways
46. Metabolic fluxes in riboflavin-producing Bacillus subtilis
47. A 'top-down' approach to the determination of control coefficients in metabolic control theory